moderate Severity

Cladosporium Mold Allergy: Most Abundant, Less Potent Than Alternaria

Cladosporium is the most frequently occurring fungal genus in outdoor air worldwide β€” counts reaching 50,000 spores per cubic meter in summer β€” yet it requires 30 times more spores than Alternaria to trigger symptoms (3,000 vs 100 per mΒ³). It affects approximately 8% of the general population and peaks May through August. Despite being the third most studied mold allergen, AIT evidence is essentially nonexistent and not recommended.

moderatePeak: May–AugUpdated April 24, 2026

Free Β· 5 min Β· Insurance accepted

Reviewed by Dr. Chet Tharpe, M.D.
As seen inUSA TODAYMen's HealthCBSForbes
The numbers
Headline stat
0,000/mΒ³
Symptom threshold
US prevalence
0.0–20%
Americans affected
~0%
Peak season
May–Aug
Symptoms tracked
0
01Overview

What Is Cladosporium Mold Allergy?

Cladosporium is the most frequently occurring fungal genus in outdoor air worldwide β€” with approximately 772 or more named species β€” yet it occupies a paradoxical position in the mold allergy hierarchy.

It is numerically dominant (counts reaching 15,000–50,000 spores/mΒ³ in summer) but relatively low in potency per spore. Where Alternaria triggers symptoms in sensitized patients at just 100 spores/mΒ³, Cladosporium requires approximately 3,000 spores/mΒ³ β€” making it 30 times less potent per unit concentration. This abundance-versus-potency paradox is the editorial anchor for understanding Cladosporium's clinical role.

Cladosporium belongs to phylum Ascomycota, class Dothideomycetes, order Capnodiales. Its conidia are elliptical, dematiaceous (darkly pigmented), measuring 3–5 Β΅m aerodynamic diameter β€” highly respirable and capable of reaching pulmonary regions. The mold is psychrophilic (grows at βˆ’6 to βˆ’10Β°C) and xerophilic (tolerates water activity as low as 0.86–0.88), allowing it to survive in conditions that kill most other molds.

Sensitization prevalence is approximately 8% in the general population and 5.8–20% in asthmatics. Eight allergen proteins have been characterized; the dominant major allergen is Cla h 8 (mannitol dehydrogenase), with 57% IgE recognition β€” the highest of any Cladosporium protein. Cross-reactivity with Alternaria through shared enolase (Cla h 6/Alt a 6) and mannitol dehydrogenase (Cla h 8/Alt a 8 at 85.7% sequence identity) creates a complex diagnostic picture where some apparent Cladosporium sensitization actually reflects primary Alternaria sensitivity.

02Symptoms

Cladosporium Allergy Symptoms

Recognizing symptoms early helps you get the right treatment faster.

Nasal congestion and sneezing

mild

Classic allergic rhinitis peaking during May through October; worsens on warm, dry, windy afternoons when Cladosporium counts reach diurnal peaks.

Runny nose (rhinorrhea)

mild

Watery nasal discharge from mast cell degranulation triggered by inhaled Cladosporium conidia; often continuous during peak season in sensitized patients.

Itchy, watery eyes

mild

Allergic conjunctivitis causing redness, tearing, and intense itching during summer outdoor activities when Cladosporium counts peak in the afternoon.

Postnasal drip

mild

Chronic mucus drainage causes throat clearing, cough, and sleep disruption throughout the May to October season; often accompanies other rhinitis symptoms.

Persistent cough

mild

A dry, tickling cough reflecting lower airway irritation from mold spore inhalation; may worsen in the late afternoon when outdoor counts peak.

Wheezing and asthma exacerbation

moderate

Bronchospasm from Cladosporium-triggered IgE-mediated lower airway inflammation; particularly prominent in patients co-sensitized with Alternaria.

Thunderstorm-amplified asthma (dual sensitized)

severe

Patients sensitized to both Alternaria and Cladosporium have an OR of 63.97 for thunderstorm asthma β€” seek emergency care immediately if severe dyspnea develops during summer thunderstorm events.

When to see a doctor

Cladosporium allergy produces symptoms typical of outdoor mold sensitization during the May through October peak season: allergic rhinitis, allergic conjunctivitis, and asthma exacerbation. Because of its lower potency per spore compared to Alternaria, Cladosporium-only sensitized patients tend to have milder symptoms than Alternaria-sensitized counterparts at equivalent spore counts β€” but the sheer abundance of Cladosporium means total allergen exposure dose can still be substantial. Patients co-sensitized to both Alternaria and Cladosporium face multiplicatively elevated risk. The Cambridge UK thunderstorm asthma data showed an OR of 9.31 for Alternaria-alone sensitization and an OR of 63.97 for those with dual Alternaria and Cladosporium sensitization β€” illustrating that co-sensitization confers dramatically amplified asthma risk that is not predictable from either allergen alone. The unique SPT-sIgE concordance problem with Cladosporium deserves mention: concordance can be as low as 30%, meaning that a significant proportion of patients who test positive on skin prick will be negative on blood IgE and vice versa. This is the lowest concordance of any major allergenic mold and means both test modalities should be used for definitive diagnosis in ambiguous cases. Seek emergency care immediately if you experience severe dyspnea not responding to rescue bronchodilators β€” particularly during thunderstorm events in summer if you are co-sensitized with Alternaria.

Cladosporium and Asthma

Cladosporium sensitization contributes to mold-driven asthma, though with less individual severity than Alternaria per unit allergen exposure. Its clinical importance in asthma is amplified by two factors: its extraordinary abundance (ensuring high cumulative dose even at lower potency per spore), and its cross-reactive relationship with Alternaria that can mask the true driver of sensitization and complicate immunotherapy planning. The thunderstorm asthma data from the Cambridge 2000 UK event is the clearest quantification of Cladosporium's asthma contribution: patients sensitized only to Alternaria had an OR of 9.31 for thunderstorm asthma; those co-sensitized with Cladosporium had an OR of 63.97 β€” a 7-fold amplification. This makes Cladosporium co-sensitization one of the strongest asthma risk multipliers identified in the thunderstorm asthma literature. For component-resolved diagnostics in asthmatic patients: rCla h 8 (the only commercially available Cladosporium molecular allergen) alongside rAlt a 1 helps distinguish primary Cladosporium sensitization from Alternaria-primary co-reactivity via the shared enolase pathway. This distinction matters because Alternaria-targeted immunotherapy exists with strong evidence, while Cladosporium-targeted AIT has essentially no evidence base.

If left untreated

Complications of Cladosporium Allergy

Left unmanaged, Cladosporium allergy can progress from seasonal inconvenience to chronic, quality-limiting disease. The 5–6 month peak season (May through October) means more than half the year is affected in sensitized patients in temperate regions, with significant impact on outdoor activities, sleep, and productivity. Chronic sinusitis from persistent nasal inflammation is the most common complication. Airway remodeling from recurrent asthma exacerbations β€” particularly in patients with high-count summer exposure β€” can cause permanent lung function decline if asthma is inadequately controlled. Sleep disruption from nocturnal coughing and nasal congestion further compounds the functional impact. For patients co-sensitized with Alternaria, the thunderstorm asthma risk is a serious safety consideration requiring an active emergency action plan. The OR of 63.97 for thunderstorm asthma in dual-sensitized patients makes this one of the highest-risk asthma scenarios associated with any allergen combination. Children with asthma and dual mold sensitization deserve particular attention β€” school emergency plans should explicitly address thunderstorm asthma risk during summer term.

Chronic sinusitis

Persistent Cladosporium-driven nasal inflammation across the 5–6 month peak season impairs mucociliary clearance and creates recurring bacterial sinus infections.

Airway remodeling

Recurrent asthma exacerbations from seasonal Cladosporium exposure cause cumulative structural bronchial changes including subepithelial fibrosis and smooth muscle hypertrophy, potentially reducing irreversible lung function.

Thunderstorm asthma (dual Alternaria co-sensitization)

Co-sensitized patients face OR 63.97 for thunderstorm asthma β€” among the highest event-specific asthma risks documented; requires emergency action plan and awareness of thunderstorm weather patterns May–October.

Diagnostic misattribution

The SPT-sIgE discordance (as low as 30%) and cross-reactivity with Alternaria can lead to incorrect attribution of symptoms to Cladosporium when primary Alternaria sensitization is the true driver β€” with consequences for immunotherapy candidacy.

03Why it happens

Causes and Risk Factors for Cladosporium Sensitization

Cladosporium sensitization occurs through repeated inhalation of highly respirable 3–5 Β΅m diameter conidia during outdoor activities β€” particularly in summer when counts peak in the thousands to tens of thousands per cubic meter. The mold is primarily outdoor but ranks among the top three most common indoor airborne fungi, colonizing damp surfaces and water-damaged building materials as a secondary colonizer.

Common Species

Most studied Cladosporium; primary basis for allergen characterization

Cladosporium herbarum

Second most common species; abundant in both indoor and outdoor air

Cladosporium cladosporioides

Extremophilic variant; particularly cold-tolerant

Cladosporium sphaerospermum

Cladosporium allergy follows classic IgE-mediated (Type I) hypersensitivity. Inhaled conidia release allergen proteins β€” particularly Cla h 8 (mannitol dehydrogenase), Cla h 6 (enolase), and Cla h 9 (serine protease) β€” that are processed by airway dendritic cells and presented to T lymphocytes, promoting Th2 differentiation and IgE antibody production. IgE molecules bind to FcΞ΅RI receptors on mast cells and basophils lining the bronchial mucosa. Repeat Cladosporium exposure cross-links IgE and triggers mast cell degranulation, releasing histamine, leukotrienes, and prostaglandins β€” causing nasal congestion, bronchospasm, and conjunctivitis within minutes. The serine protease activity of Cla h 9 may independently facilitate allergen penetration through mucosal epithelial barriers.

Geographic and regional variation in sensitization rates is significant. Portland, Oregon, leads US cities at 10.3% sensitization prevalence; Northern European populations show 9.9%. Higher sensitization in temperate, humid climates correlates with prolonged high-count seasons. The mold's exceptional cold tolerance and xerophilicity means it is present in outdoor air for more months of the year than most other allergenic molds β€” from early spring through late fall in most temperate climates, with lower-level persistence even in winter.

The cross-reactivity with Alternaria via enolase creates an important diagnostic consideration. A patient who tests positive to Cladosporium in a standard mold panel may actually have primary Alternaria sensitization through the shared Alt a 6/Cla h 6 enolase pathway β€” with cross-reactive IgE appearing positive on Cladosporium testing. Component-resolved diagnostics using rAlt a 1 (Alternaria-specific, does not cross-react with Cladosporium) and rCla h 8 (the best available Cladosporium-specific marker) helps resolve this ambiguity. The distinction matters clinically because Alternaria-targeted immunotherapy exists; Cladosporium-targeted AIT does not.

Who's most affected

Risk factors to watch for

01

Temperate humid climate residence

Prolonged warm, humid summers in temperate North America and Northern Europe maintain high ambient Cladosporium counts across a longer seasonal window, increasing cumulative sensitization opportunity.

02

Outdoor occupational or recreational exposure

Farming, landscaping, outdoor athletics, and recreational activities during summer months increase cumulative inhalation exposure to Cladosporium during its peak count season.

03

Atopic constitution

Pre-existing IgE-mediated conditions (hay fever, asthma, eczema) lower the sensitization threshold for additional environmental allergens including Cladosporium.

04

Alternaria co-sensitization

The shared enolase pathway (Cla h 6/Alt a 6) means that patients sensitized to Alternaria may appear Cladosporium-sensitized on whole-extract testing β€” component testing is needed to disentangle primary versus cross-reactive sensitization.

05

Water-damaged indoor environment

Cladosporium is a secondary indoor colonizer on damp surfaces; chronic indoor exposure in water-damaged buildings adds a year-round sensitization component to the seasonal outdoor load.

The Allergy Cascade

1.Exposure

Allergen contact

2.Detection

Immune recognition

3.IgE Response

Antibody production

4.Mast Cells

Histamine release

5.Symptoms

Allergic reaction

05Diagnosis

Diagnosing Cladosporium Mold Allergy

Cladosporium allergy diagnosis is more nuanced than for most other outdoor allergens due to two distinctive challenges: SPT-sIgE concordance as low as 30% (meaning a single test modality misses many true positives), and cross-reactivity with Alternaria via shared enolase (Cla h 6/Alt a 6) and mannitol dehydrogenase (Cla h 8/Alt a 8 at 85.7% identity) that can make apparent Cladosporium sensitization actually reflect primary Alternaria sensitivity. Skin prick testing with Cladosporium herbarum extract (ImmunoCAP m2 target species) is widely available. Specific IgE blood testing (ImmunoCAP m2) provides complementary data. The combination of both tests β€” one or both positive β€” captures a higher proportion of genuinely sensitized patients than either alone, given the low concordance. In patients where both SPT and sIgE are available, discordant results (SPT positive/sIgE negative or vice versa) are not unusual for Cladosporium and do not definitively rule in or out sensitization. For component-resolved diagnostics, rCla h 8 (NADP-dependent mannitol dehydrogenase) is the only commercially available Cladosporium molecular allergen β€” detecting the dominant major allergen with 57% IgE recognition. Testing rCla h 8 alongside rAlt a 1 allows the clinician to determine whether Cladosporium-positive whole-extract results represent genuine primary Cladosporium sensitization (rCla h 8 positive, rAlt a 1 negative) or Alternaria-driven cross-reactivity (rAlt a 1 positive, rCla h 8 cross-reactive via enolase). For patients interested in initial mold allergy screening, at-home allergy testing services such as Curex offer broad environmental panels covering 40+ allergens including mold species, with results typically within 5 days and insurance coverage often accepted β€” a practical first step before specialist evaluation for the more detailed Cladosporium CRD workup.

Skin Prick Test (SPT) with Cladosporium herbarum extract

A small amount of C. herbarum extract is placed on the forearm with a lancet; a wheal β‰₯3 mm at 15 minutes indicates sensitization. Available at most allergy clinics; concordance with sIgE as low as 30% means both tests are recommended.

Specific IgE Blood Test (ImmunoCAP m2)

Measures IgE antibodies against Cladosporium herbarum whole extract. Can be performed while the patient continues antihistamines. Results expressed in kUA/L with established thresholds.

Component-Resolved Diagnostics: rCla h 8 + rAlt a 1

rCla h 8 (mannitol dehydrogenase) is the only commercially available Cladosporium molecular allergen, detecting sensitization in 57% of cases. Combined with rAlt a 1 (Alternaria-specific, no Cladosporium cross-reactivity), this panel differentiates primary Cladosporium sensitization from Alternaria-driven cross-reactive IgE via the enolase pathway.

At-home testing

Test from home with Curex

Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.

Take the allergy quiz
Insurance acceptedBoard-certified allergists
06Treatment

Treating Cladosporium Mold Allergy

See how different approaches stack up for managing your allergy symptoms long-term.

Cladosporium allergy treatment combines allergen exposure reduction, pharmacological symptom management, and β€” because Cladosporium-specific immunotherapy is not recommended β€” treatment of any confirmed concurrent Alternaria sensitization with evidence-based AIT.

For allergic rhinitis, second-generation antihistamines are first-line, with intranasal corticosteroids offering the highest single-medication efficacy for persistent symptoms. Starting nasal steroids 2–4 weeks before the May onset of peak Cladosporium season maximizes efficacy through preseason mucosal conditioning.

Asthma management follows standard stepwise guidelines: inhaled corticosteroids as maintenance, short-acting beta-agonists for rescue. Patients with moderate-severe asthma during the May–October season should discuss a written Asthma Action Plan with their allergist that explicitly addresses thunderstorm weather patterns given the dual-sensitization amplification risk.

Cladosporium AIT extracts exist and are available in mold mix preparations, but: only one very early controlled trial exists (Dreborg 1986, 16 children), meta-analysis noted that the majority of systemic side effects from standard mold immunotherapy panels came from Cladosporium extract, and international consensus guidelines do NOT recommend Cladosporium-specific immunotherapy. The risk-benefit ratio does not favor AIT for Cladosporium sensitization as an isolated indication.

Allergen avoidance strategies

Schedule outdoor activities for early morning (before 10 AM) when Cladosporium diurnal counts are lowest; limit outdoor exposure on high-count days (warm, humid afternoons); keep windows closed during afternoon peak hours; shower after outdoor activities.

N/A

Reduces daily allergen dose; morning timing exploits the diurnal count pattern; significant quality-of-life benefit during peak season

Second-Generation Antihistamines

H1 receptor antagonists reduce sneezing, rhinorrhea, and conjunctival itching driven by Cladosporium-sensitized mast cell degranulation. Effective for mild-to-moderate rhinitis during peak season.

Cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra), levocetirizine (Xyzal)

Studies support 40–60% reduction in rhinitis symptom scores

Intranasal Corticosteroids

Topical nasal steroids are the most effective single medication for persistent Cladosporium-driven rhinitis. Starting 2–4 weeks before peak season (early to mid-April) maximizes benefit through preseason mucosal preparation.

Fluticasone (Flonase), mometasone (Nasonex), budesonide (Rhinocort), triamcinolone (Nasacort)

Evidence demonstrates 40–70% reduction in nasal symptom scores; best with preseason start

Inhaled Corticosteroids (Asthma maintenance)

Daily inhaled steroids reduce eosinophilic airway inflammation in Cladosporium-driven asthma; essential maintenance for patients with persistent asthma during peak mold season.

Fluticasone (Flovent), budesonide (Pulmicort), beclomethasone (QVAR)

Consistent evidence for 40–60% reduction in asthma exacerbation frequency

Alternaria-targeted allergen immunotherapy (if co-sensitized)

For patients who test positive to both Cladosporium and Alternaria, and where rAlt a 1 confirms genuine primary Alternaria sensitization, Alternaria-targeted SCIT or SLIT addresses the immunologically dominant mold driver and may reduce cross-reactive Cladosporium IgE indirectly via the shared enolase pathway.

Alternaria alternata SCIT or SLIT formulations

Alternaria AIT shows 63.5% symptom-medication score reduction at 3 years (SCIT) and 97% clinical improvement at 3 years (SLIT); no direct Cladosporium AIT data

Traditional

  • NoTreats root cause
  • NoLong-lasting relief
  • YesAt-home treatment
  • YesNo office visits
  • YesLow side effects
  • PartialEstimated cost

Allergy Shots (SCIT)

  • YesTreats root cause
  • YesLong-lasting relief
  • NoAt-home treatment
  • NoNo office visits
  • PartialLow side effects
  • PartialEstimated cost

Immunotherapy (SLIT)

Recommended
  • YesTreats root cause
  • YesLong-lasting relief
  • YesAt-home treatment
  • YesNo office visits
  • YesLow side effects
  • YesEstimated cost
Immunotherapy

Immunotherapy for Cladosporium Allergy

Instead of masking symptoms, immunotherapy retrains your immune system.

The current immunotherapy landscape for Cladosporium allergy is essentially a null finding β€” and understanding why illuminates important principles about mold AIT generally. Only one early controlled trial of Cladosporium AIT exists: Dreborg et al. (1986), 16 children, showing some clinical improvement. Meta-analysis of standard mold immunotherapy panels subsequently found that the majority of systemic side effects attributed to mold extracts came specifically from Cladosporium, raising safety concerns that have not been resolved in subsequent trials (because no subsequent trials have been conducted). International consensus guidelines from AAAAI, EAACI, and WAO do NOT recommend Cladosporium-specific allergen immunotherapy for allergic rhinitis or asthma. This is a stark contrast with Alternaria β€” the sole mold with multiple DBPC-RCTs β€” and explains the critical importance of component-resolved diagnostics in Cladosporium-positive patients. If rCla h 8 testing reveals that the detected IgE is primarily Alternaria-driven cross-reactivity (rAlt a 1 positive, rCla h 8 negative or weakly positive), the patient is actually a strong candidate for Alternaria-targeted SLIT or SCIT. If rCla h 8 confirms primary Cladosporium sensitization, AIT is not recommended and management is pharmacological. For patients with primary Cladosporium sensitization plus concurrent confirmed sensitizations to treatable allergens β€” dust mites, grass pollen, animal dander β€” sublingual immunotherapy targeting those allergens reduces overall allergic burden. Providers like Curex offer custom SLIT with plan-specific pricing (https://getcurex.com/learn/curex-pricing) based on each patient's allergen panel β€” enabling targeted treatment of confirmed IgE-mediated allergens even when Cladosporium-specific desensitization is unavailable. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026), clinically meaningful symptom improvement rose to 45% of patients by two years, with quality-of-life improvement reaching 90.7% and adherence above 90%.

1Step 1

Component testing to identify primary sensitization

Test rCla h 8 alongside rAlt a 1 to determine whether apparent Cladosporium sensitization reflects primary Cladosporium allergy or Alternaria-driven cross-reactive IgE through the shared enolase pathway β€” this determines AIT candidacy.

2Step 2

Alternaria AIT if cross-reactivity confirmed

If rAlt a 1 is positive and primary Alternaria sensitization is confirmed, Alternaria-targeted SLIT or SCIT addresses the dominant mold driver β€” with the strongest mold AIT evidence base including 63.5% symptom improvement at 3 years.

3Step 3

Treat confirmed concurrent allergens with SLIT

Identify and treat co-sensitizations to dust mites, grass pollen, pet dander, or other allergens with evidence-based immunotherapy β€” reducing overall allergic burden even when Cladosporium-specific AIT is not indicated.

4Step 4

Seasonal asthma action plan

Develop a written Asthma Action Plan with an allergist that explicitly addresses the peak Cladosporium season (May–October) and the elevated thunderstorm asthma risk in patients with dual Alternaria/Cladosporium co-sensitization.

β€œNo evidence-based Cladosporium-specific AIT; Alternaria SLIT shows 97% clinical improvement at 3 years in dual-sensitized patients where Alternaria is the primary driver”

Curex drops

Cladosporium is everywhere β€” find out if it's your trigger

If your symptoms track with warm, dry afternoons outdoors, mold could be part of the picture. Take Curex's free quiz to explore testing and at-home treatment.

  • MD-led
    Board-certified allergists
  • Plan-specific
    Pricing Β· Confirm your quote
  • 50K+
    Patients treated
  • HSA/FSA
    Eligible
Living with it

Living with Cladosporium Mold Allergy

Living with Cladosporium allergy means navigating 5–6 months of moderate-to-high outdoor spore loads every year. The good news: Cladosporium is manageable with consistent medication, strategic timing of outdoor activities, and indoor air quality management. The challenge: without immunotherapy options (unlike Alternaria), the same annual treatment cycle repeats indefinitely unless concurrent allergen sensitivities can be addressed with AIT. The most impactful lifestyle habit for Cladosporium-allergic patients is adopting the early morning outdoor schedule. Set a summer personal rule: all outdoor activities β€” running, gardening, cycling, dog walking β€” before 10 AM. This single habit can reduce daily allergen inhalation dose by 50–70% during peak season, with no pharmacological intervention needed. For patients with asthma, proactive season preparation is critical. Scheduling an allergist appointment in April β€” before the May peak β€” allows time to adjust asthma controller medications, confirm rescue inhaler supplies, and complete any pre-season peak flow measurements to establish baseline. For patients with dual Alternaria/Cladosporium co-sensitization, this appointment should explicitly produce a written Asthma Action Plan addressing thunderstorm triggers. Tracking local mold counts throughout summer via AAAAI's NAB station data or weather apps with mold count integration helps patients make daily activity decisions β€” particularly whether afternoon outdoor plans should be postponed to the following morning.

  • Master the morning rule

    Establish a personal summer rule: all outdoor activities before 10 AM. Cladosporium counts follow a consistent diurnal pattern, rising from mid-morning and peaking in the early to mid-afternoon. Running before 10 AM rather than at 5 PM can cut your inhaled allergen dose dramatically β€” without changing the activity, only the timing. Build this habit in May so it is automatic by the July–August peak.

  • Dual-sensitization thunderstorm protocol

    If testing confirms co-sensitization with Alternaria, you carry one of the highest known risks for thunderstorm asthma (OR 63.97). Before each summer, establish a thunderstorm protocol with your allergist: carry your rescue inhaler at all times May through October, close windows immediately when storm warnings are issued in the afternoon and evening, and have a written threshold for calling emergency services if bronchodilator response is inadequate.

  • Component testing conversation

    Many patients with apparent Cladosporium sensitization on standard whole-extract testing actually have primary Alternaria sensitization with cross-reactive IgE β€” and those patients ARE candidates for Alternaria immunotherapy with strong evidence. Ask your allergist about rCla h 8 and rAlt a 1 component testing to determine which side of this diagnostic split you fall on. If Alternaria is the primary driver, SLIT offers the prospect of long-term disease modification rather than indefinite symptom management.

Cladosporium Season: Summer Through Early Fall

Cladosporium has one of the broadest seasonal windows of any allergenic mold, owing to its psychrophilic (cold-tolerant) biology. The main outdoor peak runs from May through August, with counts reaching 15,000–50,000 spores/mΒ³ in temperate North American and European climates during hot, humid periods. A secondary shoulder occurs in September as autumn temperatures remain tolerable for Cladosporium growth. The clinical significance threshold β€” approximately 3,000 spores/mΒ³ β€” is exceeded during most summer months in high-Cladosporium regions. However, it is useful for patients to understand that even on days above this threshold, Cladosporium triggers symptoms with far lower severity per spore than Alternaria. The thunderstorm asthma phenomenon that makes Alternaria uniquely dangerous (OR 9.31 for Alternaria-sensitized patients; OR 63.97 for co-sensitized with Cladosporium) demonstrates how co-sensitization amplifies the Cladosporium contribution beyond its standalone potency. Diurnal patterns matter practically: Cladosporium counts peak in the afternoon β€” late morning through early evening β€” unlike some other molds that release primarily at night or during rain. Planning outdoor activities for early morning hours (before 10 AM) provides significant daily exposure reduction during the summer peak season.

Spring

March - May

low intensity

Summer

June - August

high intensity

Fall

September - October

medium intensity

Winter

November - February

low intensity

Reducing Cladosporium Exposure

Cladosporium prevention exploits the mold's predictable diurnal pattern: counts peak in the afternoon and are lowest in the early morning. Scheduling outdoor exercise, gardening, and outdoor events for before 10 AM provides consistent exposure reduction throughout the peak May–October season. Monitoring mold counts is more feasible than many patients realize. AAAAI's National Allergy Bureau (NAB) network reports certified mold counts during the allergy season. On days when counts exceed 3,000 spores/mΒ³ (the Cladosporium clinical significance threshold), limiting outdoor afternoon exposure is warranted. Weather apps increasingly integrate mold count data alongside pollen and air quality. Indoor measures: keeping windows closed during peak afternoon hours (noon to 6 PM) prevents outdoor Cladosporium from entering the home. HEPA air purifiers capture the 3–5 Β΅m diameter Cladosporium conidia effectively; place in bedrooms for overnight protection. Managing indoor humidity to 30–50% prevents indoor Cladosporium colonization on damp building materials. For patients with dual Alternaria and Cladosporium sensitization, all thunderstorm precautions applicable to Alternaria apply equally β€” given the dramatic (OR 63.97) risk amplification from co-sensitization.

Schedule outdoor activities before 10 AM

Cladosporium counts peak in the afternoon; planning outdoor exercise, gardening, and recreational activities for early morning provides consistent daily exposure reduction throughout the 5-month peak season.

Monitor mold counts with AAAAI NAB

Check certified mold counts through AAAAI's National Allergy Bureau network; restrict outdoor afternoon activities on days exceeding 3,000 spores/mΒ³ β€” the Cladosporium clinical significance threshold.

Close windows during afternoon peak hours

Keep windows and doors closed from noon to 6 PM during summer months when Cladosporium counts peak; air conditioning with HEPA filtration maintains indoor comfort without bringing in outdoor spores.

Run HEPA air purifiers in sleeping areas

Cladosporium's 3–5 Β΅m conidia are effectively captured by true HEPA filters; running a purifier in the bedroom overnight reduces the cumulative spore exposure during sleep.

Close windows before thunderstorms

For patients co-sensitized with Alternaria, thunderstorm events carry dramatically amplified asthma risk (OR 63.97 dual-sensitized vs. 9.31 Alternaria-only); close windows at the first sign of approaching summer storms and stay indoors.

Long-term outlook

Prognosis for Cladosporium Allergy

For patients with primary Cladosporium sensitization managed consistently with antihistamines, nasal steroids, and asthma controller medications, the prognosis for symptom control is generally good. The seasonal pattern β€” May through October with a clear winter respite β€” provides natural relief for part of the year. Most patients can maintain reasonable quality of life with appropriate pharmacological management during peak season. The most important prognosis determinant is accurate identification of the sensitization driver. Patients who test positive on Cladosporium whole extract but are actually primarily Alternaria-sensitized via the enolase cross-reactivity pathway may be missing their best treatment opportunity β€” Alternaria-targeted immunotherapy β€” due to diagnostic misattribution. Component testing (rCla h 8, rAlt a 1) should be pursued in any Cladosporium-positive patient with moderate-severe mold allergy or difficult-to-control asthma. Without disease-modifying therapy, the same annual treatment cycle will repeat indefinitely. Long-term, without immunotherapy, there is risk of progressive airway remodeling in inadequately controlled asthmatic patients. The prognosis improves substantially when concurrent treatable allergen sensitizations are identified and addressed with AIT, reducing the total allergic burden on the airway across the entire year β€” not just during Cladosporium season.

What to expect

Key takeaways

01

Cladosporium is the world's most abundant airborne mold but requires 30 times more spores than Alternaria to trigger symptoms β€” abundance compensates for lower potency in total allergen dose delivered.

02

SPT-sIgE concordance as low as 30% is a distinctive Cladosporium diagnostic challenge β€” both test types should be obtained in equivocal cases rather than relying on either alone.

03

Cladosporium-specific allergen immunotherapy is NOT recommended by international guidelines; the productive AIT pathway is through concurrent Alternaria sensitization (if confirmed by rAlt a 1 component testing) or other co-allergens.

04

Dual Alternaria and Cladosporium co-sensitization carries OR 63.97 for thunderstorm asthma β€” patients with this profile should have an explicit summer thunderstorm Asthma Action Plan and never be without a rescue inhaler May through October.

Diet

Diet and Cladosporium Allergy

Diet is not a primary driver of Cladosporium mold allergy symptoms, which are caused by inhaled airborne spores rather than food ingestion. Cross-reactivity between Cladosporium and food allergens has not been well-documented in the way that some pollen-food syndromes have been characterized. Patients with broad mold allergy may occasionally notice oral tingling or gastrointestinal symptoms after eating mold-containing foods β€” aged cheeses, fermented products (soy sauce, vinegar, wine), mushrooms β€” reflecting general mold cross-reactivity rather than Cladosporium-specific reactions. If consistent symptom patterns are noticed, discuss them with an allergist rather than self-restricting broadly. An anti-inflammatory dietary pattern (omega-3 fatty acids, quercetin-rich fruits and vegetables) is a reasonable general health approach that may support immune regulation but does not substitute for allergy treatment.

Foods that help

  • Fatty fish (salmon, mackerel)

    Omega-3 fatty acids support anti-inflammatory immune pathways and may modestly reduce allergic airway inflammation.

  • Apples and onions

    Rich in quercetin, a natural flavonoid with documented antihistamine and mast cell-stabilizing properties.

Cladosporium occupies a peculiar niche β€” it fills the air with more spores than any other fungus yet requires 30 times the concentration of Alternaria to trigger the same response. The real diagnostic trap is its cross-reactive enolase protein that can produce false Cladosporium positivity in patients whose primary sensitization is actually Alternaria.

Board-certified allergist (clinical reviewer for this article)
FAQ

Frequently Asked Questions

Cladosporium is the most frequently occurring fungal genus in outdoor air worldwide, with over 772 recognized species (it was historically called Hormodendrum). Its ecological success stems from exceptional biological adaptability: it is psychrophilic (grows at temperatures as low as βˆ’6 to βˆ’10Β°C), xerophilic (tolerates low water activity of 0.86–0.88), and produces abundant small conidia (3–5 Β΅m) that disperse readily by wind. These traits allow Cladosporium to colonize virtually any plant surface, decaying organic matter, or damp indoor substrate across all four seasons in temperate climates. Summer counts regularly reach 15,000–50,000 spores per cubic meter. Despite being the most abundant mold in outdoor air, it is roughly 30 times less potent per spore than Alternaria in triggering symptoms β€” the abundance-versus-potency paradox that defines Cladosporium's clinical position.

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.

Get started today

Ready to treat your Cladosporium Mold allergies for good?

Get a personalized treatment plan from board-certified allergists, delivered to your door.

Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.

Compare Curex plan pricing
3-minute quizBoard-certified allergistsProgram-specific pricing Β· Confirm your written quote

Questions about Curex itself?

Straight answers about the company, the evidence, what patients report, and what it costs β€” including the parts that are not flattering.

Afternoon symptoms that track with outdoor mold counts?

If your symptoms track with warm, dry afternoons outdoors, mold could be part of the picture. Take Curex's free quiz to explore testing and at-home treatment.

Take the free allergy quiz

Ready to treat your allergies at the source?

Take the free allergy quiz to find out if immunotherapy is right for you and get started with personalized treatment today.

Take Free Allergy Quiz